SolGel Technologies (SLGL)
(Delayed Data from NSDQ)
$0.52 USD
+0.03 (5.10%)
Updated Nov 1, 2024 03:56 PM ET
3-Hold of 5 3
D Value F Growth A Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SLGL 0.52 +0.03(5.10%)
Will SLGL be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for SLGL based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SLGL
SolGel Technologies (SLGL) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
All You Need to Know About SolGel Technologies (SLGL) Rating Upgrade to Strong Buy
SLGL: What are Zacks experts saying now?
Zacks Private Portfolio Services
Sol-Gel Technologies Ltd. (SLGL) Surpasses Q2 Earnings and Revenue Estimates
Cue Biopharma, Inc. (CUE) Reports Q2 Loss, Tops Revenue Estimates
Amphastar Pharmaceuticals (AMPH) Tops Q2 Earnings and Revenue Estimates
Other News for SLGL
Sol-Gel Technologies Announces Key Shareholder Decisions
Biotech Alert: Searches spiking for these stocks today
Raymond James gets more bearish on Sol-Gel Technologies, downgrades shares
UPDATE: Sol-Gel Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
Sol-Gel Technologies GAAP EPS of $0.07 beats by $0.26, revenue of $5.43M beats by $3.82M